$PMCB Pharmacyte Biotech Inc (OTCMKTS:PMCB) reported that its senior management will attend the annual meeting of the ASCO. The theme of this meeting is focused on bringing a difference in cancer care. Kenneth L. Waggoner, the CEO, reported that this year’s yearly meeting of ASCO will be most significant as they work towards registering the first patient in their planned clinical study in locally advanced pancreas cancer.
Market Data 
Markets 
